NASDAQ:CGEM
Cullinan Therapeutics, Inc. Common Stock
- Stock
Last Close
19.91
26/07 20:00
Market Cap
1.16B
Beta: 0.10
Volume Today
593.36K
Avg: 224.28K
PE Ratio
−4.92
PFCF: −5.42
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 615K - | 5.31M 762.85% | 6.42M 21.06% | 2.91M 54.63% | 2.58M 11.60% | ||
average receivables | |||||||
book value per share | -1.80 - | -2.11 16.76% | -1.88 10.94% | 9.81 623.05% | 11.85 20.76% | 10.92 7.82% | |
capex per share | -0.02 - | -0.00 95.47% | -0.00 76.62% | -0.03 - | -0.01 80.04% | ||
capex to depreciation | -6.07 - | -0.29 95.29% | -0.16 43.55% | -12.18 - | -0.67 94.49% | ||
capex to operating cash flow | 0.02 - | 0.00 95.03% | 0.00 64.90% | 0.01 - | 0.00 82.68% | ||
capex to revenue | |||||||
cash per share | 2.95 - | 5.09 72.40% | 5.08 0.32% | 15.36 202.45% | 19.07 24.17% | 11.24 41.05% | |
days of inventory on hand | |||||||
days payables outstanding | 2.94K - | ||||||
days sales outstanding | |||||||
debt to assets | 0.01 - | 0.01 19.97% | |||||
debt to equity | 0.01 - | 0.01 18.41% | |||||
dividend yield | |||||||
earnings yield | -0.04 - | -0.03 16.49% | -0.04 18.69% | -0.10 138.28% | 0.23 338.53% | -0.36 254.99% | |
enterprise value | 308.63M - | 515.85M 67.14% | 1.07B 107.43% | 233.82M 78.15% | -68.45M 129.27% | 328.55M 579.99% | |
enterprise value over ebitda | -21.22 - | -23.24 9.49% | -17.73 23.68% | -3.44 80.60% | 0.17 104.86% | -1.73 1,131.21% | |
ev to operating cash flow | -22.78 - | -24.69 8.37% | -35.94 45.59% | -5.38 85.02% | 0.54 110.04% | -2.45 552.79% | |
ev to sales | 12.34 - | ||||||
free cash flow per share | -1.21 - | -1.08 10.43% | -0.72 33.41% | -1.01 40.15% | -2.83 180.64% | -3.24 14.38% | |
free cash flow yield | -0.04 - | -0.04 10.43% | -0.02 33.41% | -0.07 171.67% | -0.27 310.46% | -0.32 18.43% | |
graham net net | -1.87 - | -2.16 15.03% | -1.95 9.42% | 15.08 872.41% | 18.49 22.60% | 10.49 43.27% | |
graham number | 7.09 - | 7.00 1.26% | 7.20 2.81% | 18.26 153.56% | 25.62 40.34% | 30.09 17.47% | |
income quality | 0.95 - | 0.97 1.06% | 0.50 48.11% | 0.64 28.53% | -1.16 280.23% | 0.88 175.58% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -0.26 - | ||||||
interest debt per share | -12.34 - | 0.09 100.70% | |||||
inventory turnover | |||||||
invested capital | 0.01 - | 0.01 18.41% | |||||
market cap | 342.46M - | 579.10M 69.10% | 1.24B 113.82% | 664.68M 46.32% | 476.48M 28.31% | 423.39M 11.14% | |
net current asset value | -21.07M - | -40.28M 91.16% | -78.77M 95.56% | 284.75M 461.51% | 448.38M 57.46% | 448.99M 0.14% | |
net debt to ebitda | 2.33 - | 2.85 22.47% | 2.79 2.15% | 6.34 127.44% | 1.33 78.98% | 0.50 62.61% | |
net income per share | -1.24 - | -1.03 16.49% | -1.23 18.69% | -1.51 22.92% | 2.46 263.09% | -3.69 249.70% | |
operating cash flow per share | -1.18 - | -1.08 8.79% | -0.72 33.37% | -1.01 40.20% | -2.80 178.15% | -3.23 15.23% | |
payables turnover | 0.12 - | ||||||
receivables turnover | |||||||
research and ddevelopement to revenue | 3.05 - | ||||||
return on tangible assets | -0.41 - | -0.20 51.31% | -0.24 18.74% | -0.15 37.18% | 0.20 233.23% | -0.32 259.30% | |
revenue per share | 0.44 - | ||||||
roe | 0.69 - | 0.49 28.48% | 0.65 33.27% | -0.15 123.50% | 0.21 235.05% | -0.34 262.40% | |
roic | 0.73 - | 0.51 30.39% | 0.66 31.49% | -0.15 123.32% | 0.19 223.53% | -0.38 298.66% | |
sales general and administrative to revenue | 1.54 - | ||||||
shareholders equity per share | -1.80 - | -2.11 16.76% | -1.88 10.94% | 9.81 623.05% | 11.85 20.76% | 10.92 7.82% | |
stock based compensation to revenue | 1.29 - | ||||||
tangible asset value | -20.65M - | -39.91M 93.26% | -76.34M 91.28% | 425.37M 657.22% | 535.03M 25.78% | 453.89M 15.16% | |
tangible book value per share | -1.80 - | -2.06 14.29% | -1.84 10.54% | 9.87 635.50% | 11.85 19.97% | 10.92 7.79% | |
working capital | 32.90M - | 97.57M 196.60% | 197.96M 102.89% | 284.82M 43.88% | 451.97M 58.69% | 452.05M 0.02% |
All numbers in USD (except ratios and percentages)